Literature DB >> 31597886

Exosome-Derived MiRNAs as Biomarkers of the Development and Progression of Intracranial Aneurysms.

Bao Liao1, Meng-Xiao Zhou1, Feng-Kun Zhou1, Xiu-Mei Luo1, Song-Xin Zhong1, Yuan-Fang Zhou1, Yan-Sheng Qin1, Ping-Ping Li1, Chao Qin1.   

Abstract

AIM: Exosome-derived microRNAs (miRNAs) are potential diagnostic biomarkers. However, little is known about their effectiveness as diagnostic biomarkers of intracranial aneurysms (IAs). This study aimed to explore miRNA levels in plasma exosomes of patients with IA to identify potential biomarkers that predict the development and progress of IA.
METHODS: A total of 69 patients with IA and 30 healthy controls (HC) were recruited, among whom 30 had unruptured IA (UA), and 39 had ruptured IA (RA). The miRNA expression profiles of plasma exosomes in 12 IA patients (4 UA and 8 RA) and 4 HC were determined using next-generation sequencing. In addition, significantly differentially expressed miRNAs were further analyzed by Quantitative Real-Time PCR (qRT-PCR) in a validation cohort of 99 subjects.
RESULTS: From the sequencing analysis, 181 miRNAs were identified to be differently (p<0.05) expressed. Of these, 9 miRNAs were up-regulated, and 20 were down-regulated in patients with UA compared with HC. Also, 21 were up-regulated, and 10 were down-regulated in patients with RA compared with HC. In addition, compared with UA, 92 miRNAs were up-regulated in RA, whereas 29 were down-regulated. Furthermore, qRT-PCR analysis confirmed that miR-145-5p and miR-29a-3p were up-regulated in IA samples. To distinguish IA patients from controls, the area under the receiver operating characteristic curve was 0.791 for miR-29a-3p, while that of miRNA-145-5p was 0.773 in terms of discriminating whether the aneurysm was ruptured.
CONCLUSIONS: Circulating exosomal miRNAs can serve as biomarkers of the development and progression of IA.

Entities:  

Keywords:  Exosome; Intracranial aneurysm; MiR-145-5p; MiR-29a-3p; MicroRNA; Subarachnoid hemorrhage

Mesh:

Substances:

Year:  2019        PMID: 31597886      PMCID: PMC7355105          DOI: 10.5551/jat.51102

Source DB:  PubMed          Journal:  J Atheroscler Thromb        ISSN: 1340-3478            Impact factor:   4.928


  25 in total

Review 1.  Circulating microRNAs: Association with disease and potential use as biomarkers.

Authors:  Glen Reid; Michaela B Kirschner; Nico van Zandwijk
Journal:  Crit Rev Oncol Hematol       Date:  2010-12-08       Impact factor: 6.312

2.  MiR-29b Downregulation Induces Phenotypic Modulation of Vascular Smooth Muscle Cells: Implication for Intracranial Aneurysm Formation and Progression to Rupture.

Authors:  Liqian Sun; Manman Zhao; Jingbo Zhang; Ming Lv; Youxiang Li; Xinjian Yang; Aihua Liu; Zhongxue Wu
Journal:  Cell Physiol Biochem       Date:  2017-01-30

3.  Inhibition of microRNA-29b reduces murine abdominal aortic aneurysm development.

Authors:  Lars Maegdefessel; Junya Azuma; Ryuji Toh; Denis R Merk; Alicia Deng; Jocelyn T Chin; Uwe Raaz; Anke M Schoelmerich; Azad Raiesdana; Nicholas J Leeper; Michael V McConnell; Ronald L Dalman; Joshua M Spin; Philip S Tsao
Journal:  J Clin Invest       Date:  2012-01-24       Impact factor: 14.808

4.  Circulating MicroRNAs as Novel Biomarkers of Stenosis Progression in Asymptomatic Carotid Stenosis.

Authors:  Sandra Dolz; David Górriz; José Ignacio Tembl; Dolors Sánchez; Gerardo Fortea; Vera Parkhutik; Aida Lago
Journal:  Stroke       Date:  2016-11-29       Impact factor: 7.914

Review 5.  Genetics of Intracranial Aneurysms.

Authors:  Sirui Zhou; Patrick A Dion; Guy A Rouleau
Journal:  Stroke       Date:  2018-02-06       Impact factor: 7.914

Review 6.  Exosomes and exosomal miRNAs in cardiovascular protection and repair.

Authors:  Costanza Emanueli; Andrew I U Shearn; Gianni D Angelini; Susmita Sahoo
Journal:  Vascul Pharmacol       Date:  2015-04-11       Impact factor: 5.773

7.  Guidelines for the management of aneurysmal subarachnoid hemorrhage: a guideline for healthcare professionals from the American Heart Association/american Stroke Association.

Authors:  E Sander Connolly; Alejandro A Rabinstein; J Ricardo Carhuapoma; Colin P Derdeyn; Jacques Dion; Randall T Higashida; Brian L Hoh; Catherine J Kirkness; Andrew M Naidech; Christopher S Ogilvy; Aman B Patel; B Gregory Thompson; Paul Vespa
Journal:  Stroke       Date:  2012-05-03       Impact factor: 7.914

8.  MicroRNA-145, a novel smooth muscle cell phenotypic marker and modulator, controls vascular neointimal lesion formation.

Authors:  Yunhui Cheng; Xiaojun Liu; Jian Yang; Ying Lin; Da-Zhong Xu; Qi Lu; Edwin A Deitch; Yuqing Huo; Ellise S Delphin; Chunxiang Zhang
Journal:  Circ Res       Date:  2009-06-18       Impact factor: 17.367

9.  The miR-143/145 cluster reverses the regulation effect of KLF5 in smooth muscle cells with proliferation and contractility in intracranial aneurysm.

Authors:  Jichong Xu; Shuo Yan; Huaqiao Tan; Lin Ma; Hao Feng; Hongjie Han; Minmin Pan; Limin Yu; Chun Fang
Journal:  Gene       Date:  2018-09-07       Impact factor: 3.688

10.  MiRNAs as biomarkers of myocardial infarction: a meta-analysis.

Authors:  Chao Cheng; Qiang Wang; Wenjie You; Manhua Chen; Jiahong Xia
Journal:  PLoS One       Date:  2014-02-12       Impact factor: 3.240

View more
  15 in total

Review 1.  Unpacking the Role of Extracellular Vesicles in Ischemic and Hemorrhagic Stroke: Pathophysiology and Therapeutic Implications.

Authors:  Yonatan Hirsch; Joseph R Geraghty; Cory R Reiter; Eitan A Katz; Conner F Little; Matthew K Tobin; Fernando D Testai
Journal:  Transl Stroke Res       Date:  2022-05-06       Impact factor: 6.829

Review 2.  Extracellular Vesicles and Their Associated miRNAs as Potential Biomarkers in Intracranial Aneurysm.

Authors:  Yuman Li; Jiahao Wen; Dingyue Liang; Haitao Sun
Journal:  Front Mol Biosci       Date:  2022-06-20

Review 3.  Emerging Roles of Extracellular Non-Coding RNAs in Vascular Diseases.

Authors:  Yaxiong Fang; Xiaoyan Dai
Journal:  J Cardiovasc Transl Res       Date:  2022-04-22       Impact factor: 3.216

4.  Association of miRNA-145 Single Nucleotide Polymorphisms in Abdominal Aortic Aneurysms.

Authors:  Natasha Hasemaki; Nikolaos-Panagiotis Andreou; Evangelia Legaki; Athanasios Katsargyris; Maria Gazouli; Christos Klonaris
Journal:  In Vivo       Date:  2022 May-Jun       Impact factor: 2.406

Review 5.  Diagnostic and prognostic potential of circulating miRNAs for intracranial aneurysms.

Authors:  Ilgiz Gareev; Ozal Beylerli; Guang Yang; Adel Izmailov; Huaizhang Shi; Jinxian Sun; Boxian Zhao; Binbing Liu; Shiguang Zhao
Journal:  Neurosurg Rev       Date:  2020-10-23       Impact factor: 3.042

Review 6.  Potential therapeutic approaches of microRNAs for COVID-19: Challenges and opportunities.

Authors:  Alieh Farshbaf; Nooshin Mohtasham; Reza Zare; Farnaz Mohajertehran; Seyed Abdolrahim Rezaee
Journal:  J Oral Biol Craniofac Res       Date:  2020-12-30

7.  Mesenchymal stem cells-derived exosomes modulate vascular endothelial injury via miR-144-5p/PTEN in intracranial aneurysm.

Authors:  Guojun Yang; Hao Qin; Bing Liu; Xinhong Zhao; Hang Yin
Journal:  Hum Cell       Date:  2021-07-08       Impact factor: 4.174

8.  The Prediction of miRNAs in SARS-CoV-2 Genomes: hsa-miR Databases Identify 7 Key miRs Linked to Host Responses and Virus Pathogenicity-Related KEGG Pathways Significant for Comorbidities.

Authors:  Elif Damla Arisan; Alwyn Dart; Guy H Grant; Serdar Arisan; Songul Cuhadaroglu; Sigrun Lange; Pinar Uysal-Onganer
Journal:  Viruses       Date:  2020-06-04       Impact factor: 5.048

9.  Whole blood transcriptome biomarkers of unruptured intracranial aneurysm.

Authors:  Kerry E Poppenberg; Lu Li; Muhammad Waqas; Nikhil Paliwal; Kaiyu Jiang; James N Jarvis; Yijun Sun; Kenneth V Snyder; Elad I Levy; Adnan H Siddiqui; John Kolega; Hui Meng; Vincent M Tutino
Journal:  PLoS One       Date:  2020-11-06       Impact factor: 3.240

Review 10.  Molecular Pathogenesis and the Possible Role of Mitochondrial Heteroplasmy in Thoracic Aortic Aneurysm.

Authors:  A V Suslov; M A Afanasyev; P A Degtyarev; P V Chumachenko; M Bagheri Ekta; V N Sukhorukov; V A Khotina; S-F Yet; I A Sobenin; A Yu Postnov
Journal:  Life (Basel)       Date:  2021-12-13
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.